ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 241 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $427,440 | -30.6% | 10,400 | -21.2% | 0.00% | 0.0% |
Q1 2024 | $616,308 | -36.2% | 13,200 | -34.7% | 0.00% | -50.0% |
Q4 2023 | $965,964 | +218.8% | 20,200 | +137.6% | 0.00% | +100.0% |
Q3 2023 | $303,025 | -22.7% | 8,500 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $392,105 | -74.2% | 8,500 | -66.7% | 0.00% | 0.0% |
Q2 2022 | $1,522,000 | -41.6% | 25,495 | -28.9% | 0.00% | -50.0% |
Q1 2022 | $2,604,000 | -6.7% | 35,860 | +8.1% | 0.00% | 0.0% |
Q4 2021 | $2,792,000 | -28.6% | 33,188 | -23.5% | 0.00% | -33.3% |
Q3 2021 | $3,911,000 | +121.0% | 43,361 | +133.6% | 0.00% | +200.0% |
Q2 2021 | $1,770,000 | -14.3% | 18,562 | +2.3% | 0.00% | -50.0% |
Q1 2021 | $2,066,000 | -19.8% | 18,144 | -2.5% | 0.00% | -33.3% |
Q4 2020 | $2,576,000 | +126.2% | 18,606 | +34.2% | 0.00% | +200.0% |
Q3 2020 | $1,139,000 | +12.7% | 13,866 | +7.3% | 0.00% | 0.0% |
Q2 2020 | $1,011,000 | -53.5% | 12,928 | -58.8% | 0.00% | -50.0% |
Q1 2019 | $2,175,000 | +164.3% | 31,364 | +65.7% | 0.00% | +100.0% |
Q4 2018 | $823,000 | +132.5% | 18,933 | +232.1% | 0.00% | – |
Q2 2017 | $354,000 | -20.4% | 5,701 | -13.1% | 0.00% | – |
Q1 2017 | $445,000 | -26.1% | 6,558 | -23.4% | 0.00% | -100.0% |
Q4 2016 | $602,000 | -56.7% | 8,559 | -56.3% | 0.00% | 0.0% |
Q3 2016 | $1,390,000 | -78.9% | 19,588 | -81.2% | 0.00% | -85.7% |
Q1 2016 | $6,580,000 | -60.6% | 103,933 | -29.9% | 0.01% | -63.2% |
Q4 2015 | $16,681,000 | -2.6% | 148,190 | -16.7% | 0.02% | -5.0% |
Q3 2015 | $17,135,000 | +38.7% | 177,914 | +47.5% | 0.02% | +53.8% |
Q2 2015 | $12,351,000 | +485.1% | 120,625 | +254.8% | 0.01% | +550.0% |
Q1 2015 | $2,111,000 | – | 34,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 217,459 | $24,760,000 | 1.64% |
Motley Fool Asset Management LLC | 152,326 | $17,344,000 | 1.25% |
Rock Springs Capital Management LP | 450,000 | $51,237,000 | 1.12% |
AtonRa Partners | 21,017 | $2,393,000 | 1.07% |
SECTORAL ASSET MANAGEMENT INC | 112,200 | $12,775,000 | 0.97% |
EMERALD ADVISERS, LLC | 228,368 | $26,002,000 | 0.94% |
EMERALD MUTUAL FUND ADVISERS TRUST | 239,023 | $27,215,000 | 0.90% |
FEDERATED HERMES, INC. | 3,912,408 | $445,467,000 | 0.86% |
HealthCor Management, L.P. | 207,610 | $23,638,000 | 0.84% |
Atika Capital Management LLC | 66,000 | $7,515,000 | 0.65% |